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Senzaki et al Surgery for Congenital Heart Disease
Objectives: It is particularly useful to separately quantify the ventricular contractility
and loading conditions for a better understanding of the cardiovascular dynamics in
congenital heart disease, where abnormalities in chamber and loading properties may
coexist. Furthermore, ventricular contractility and loading conditions may alter inde-
pendently or simultaneously with disease progression and therapeutic intervention.
The objectives of the present study were (1) to test whether ventricular pressure-area
analysis can provide such quantitation among patients with various forms of congeni-
tal heart disease, (2) to reveal basal cardiovascular interaction in congenital heart dis-
ease by means of pressure-area analysis, and (3) to test the feasibility of this method in
a simplified and less invasive form to further enhance its clinical value.
Methods: We constructed pressure-area loops during caval occlusion by using
transthoracic echocardiographic automated border detection combined with ven-
tricular pressure recordings in 59 pediatric patients with congenital heart disease
and in 7 normal control subjects.
Results: Area measurements obtained by automated border detection were highly
reproducible, and area changes reflected volume changes. The pressure-area data pro-
vided load-independent measures of contractility, which were consistently increased
by use of dobutamine (P < .05). End-systolic and arterial elastance individually quan-
tified simultaneous changes in ventricular contractility and loading with milrinone
infusion and predicted net cardiac performance. The pressure-area analysis better char-
acterized the ventricular contractile states under a variety of loading conditions in con-
genital heart disease, whereas predominant load dependence of conventional indices
confounded them. Furthermore, pressure-area relations were reasonably estimated
from a single beat and from aortic pressure data during abdominal compression.
Conclusions: Pressure-area analysis should provide a useful modality with which to
assess cardiovascular dynamics in pediatric patients with congenital heart disease in
more detail and should thus help improve the management of patients with this disease.
With recent improvements in surgical and catheter interven-tion, together with the explosion in pharmacologic treat-ment options for pediatric patients with congenital heart dis-ease (CHD), there is a growing need for more accurate anddetailed measurements of cardiac performance. Anatomicabnormalities in CHD are generally associated with volume
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or pressure overloading (or both) of the pulmonary ventri-
cle, systemic ventricle, or both.1 Under some conditions,
overloading of one ventricle causes underloading of the
opposite ventricular chamber. Such loading abnormalities
can profoundly affect ventricular chamber mechanics.
Cyanosis superimposed on various loading conditions may
further influence myocardial performance.2 In addition to
these baseline hemodynamic characteristics in CHD, phar-
macologic, surgical, or catheter intervention often dramati-
cally alters chamber loading, which may simultaneously
accompany changes in chamber contractile function. Thus,
for cardiovascular dynamics in CHD to be better under-
stood, chamber contractility and ventricular loading condi-
tions must be separately quantified. Traditional measures of
ventricular function, such as ejection fraction (EF) or maxi-
mum rate of pressure rise (dP/dtmax), predominantly
depend on loading factors, as well as contractility, thus
falling short of this mark.
Ventricular pressure-volume (P-V) relations, in contrast,
provide a characterization of pump performance that allows
loading factors to be reasonably separated from ventricular
properties.3,4 Loading factors and ventricular properties can
in turn be coupled to predict net cardiac performance and to
evaluate ventricular energetics.4-7 Despite its potential use-
fulness in assessing cardiovascular dynamics in CHD, appli-
cation to pediatric patients with CHD has been hindered pri-
marily because of technical difficulties encountered in
measuring instantaneous ventricular volume. However, ven-
tricular chamber area can now be measured instantaneously
by means of echocardiography with automated border
detection (ABD).8,9 Area data can be combined with simul-
taneous pressure data to construct ventricular pressure-area
(P-A) relations, potentially providing a method to assess
cardiovascular function in a manner similar to that of P-V
relations. Thus, in the present study, we tested the validity of
P-A analysis in CHD that presented a diversity of ventricu-
lar morphology and loading conditions. We then analyzed
cardiovascular dynamics in the various types of CHD by
this method.
The other important aspect in the assessment of cardio-
vascular function, particularly in pediatric patients, is that
the method should be reasonably simple and less invasive.
Such methods allow data to be obtained with minimal risk
or discomfort to the patient, permitting studies to be repeat-
ed more frequently and under various test conditions. We
therefore tested whether a P-A coupling framework can be
determined by using a single P-A loop or by noninvasive
means by use of aortic pressure tracing combined with
abdominal compression.
Accordingly, the objectives of the present study were (1)
to test whether P-A relations can be used to assess cardio-
vascular dynamics in CHD in a way similar to that of P-V
relations, (2) to reveal basal ventricular-vascular interaction
in CHD by means of P-A analysis, and (3) to test the feasi-
bility of more simplified and less invasive applications of
this method.
Methods
Patients
Data were analyzed from 66 patients, of whom 7 had normal hearts
and 59 had various forms of CHD. Patient ages ranged from 1
month to 16 years (mean, 4.3 ± 4.8 years). Control subjects were
patients who had had Kawasaki disease and had normal electro-
cardiograms, coronary angiograms, and contrast ventriculography.
Patient characteristics are provided in Table 1. Written informed
consent was obtained from the parents of all patients, and the pro-
cedures were approved by The Saitama Medical School
Committee on Clinical Investigation.
Procedures
After routine cardiac catheterization and before angiography/ven-
triculography, P-A relations for the systemic ventricle were con-
structed by simultaneously measuring ventricular chamber pres-
sure and area both at rest and during varying preloads by means of
transient inferior vena caval balloon obstruction. The balloon
catheter used was a 6F catheter developed in our laboratory to min-
imize vascular injury in small children. Ventricular pressure was
measured with a high-fidelity pressure transducer mounted on a
0.014F guide wire (RADI Medical Systems AB, Uppsala, Sweden)
placed within a 4F or 5F pigtail catheter. Instantaneous ventricular
cavity area was obtained by means of an ABD echocardiographic
system8,9 (Sonos 2500; Hewlett-Packard Company, Palo Alto,
Calif) with a 3.5- or 5.5-MHz phased-array transducer.
Transthoracic 2-dimensional images were recorded from the mid-
ventricular short-axis plane with the midpapillary muscle level
used as an anatomic landmark. Overall transmit, time gain com-
pensation, and lateral gain controls were adjusted by means of
visual inspection as a compromise between cavity clutter and wall
dropout. A region of interest was then drawn immediately beyond
the endocardial border. The traced area within the region of inter-
est was automatically calculated, providing a real-time area wave-
form. P-A data were digitalized at 500 Hz by a custom-designed
data acquisition system and displayed in real time.
Data Analysis
Three to 5 consecutive steady-state beats were signal averaged and
used to generate end-diastolic and end-systolic pressure, end-dia-
stolic and end-systolic area, stroke area, area-based EF, dP/dtmax,
and the effective arterial elastance (Ea), which is a lumped measure
of ventricular afterload.5,6 Arterial load presented to the heart
should encompass both mean and pulsatile components. Although
the aortic input impedance spectra defined in the frequency
domain provide such information, it is very difficult to link such
data with time-domain or P-V (area) measurements of ventricular
function. In contrast, Ea shares common units with elastance meas-
ures of ventricular function and thus enables ventricular-arterial
interactions to be easily evaluated, while incorporating both mean
and pulsatile components of ventricular load provided by imped-
ance spectra.5,6
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Area data were normalized by the body surface area of the
patients and expressed as area indexes (end-diastolic area index
[EDAI], end-systolic area index [ESAI], and stroke area index
[SAI]). EF was calculated as SAI/EDAI and Ea as end-systolic
pressure/SAI. Data measured during varying preloads by means of
transient inferior vena caval occlusion or abdominal compression
were used to determine the end-systolic pressure-area relation
(ESPAR). Heart rate generally changed little during preload
change, but to further eliminate rate effects, only beats for which
heart rate varied by less than 5% of baseline were used for analy-
sis. Points of maximal pressure/(area-Ao), where Ao was the
ESPAR area-axis intercept, were calculated for each beat in the
series by using an iterative method to measure Ao.10,11 Data were
fit by orthogonal regression,12 yielding an ESPAR slope (end-sys-
tolic elastance [Ees]) and intercept (Ao).
Validation of area measurements by ABD. We tested the repro-
ducibility of area measurements in 34 randomly selected patients by
comparing area data recorded at the beginning of the routine catheter-
ization and those obtained during the P-A study. For 21 patients in
whom the systemic ventricle had a single outflow into the aorta,
changes in stroke area during inferior vena caval occlusion were com-
pared with those in stroke volume that were simultaneously measured
with a catheter-mounted electromagnetic flow probe (Millar
Instruments, Inc, Houston, Tex). This procedure tested whether area
changes adequately reflected volume changes. The catheter was
advanced retrogradely across the aortic valve to help stabilize it and
to keep the sensor in the center of the stream. Ascending aortic cross-
sectional area obtained from 2-dimensional echocardiograms was
used to convert flow velocity to volume flow.
Contractility response to a positive inotrope. To determine
whether P-A loops and relations adequately reflect changes in con-
tractility in response to a positive inotrope, changes in ESPAR, the
slope of dP/dtmax-EDAI relation,13 and the slope of stroke work
index (SWI)-EDAI relation14 were compared before and after the
administration of dobutamine (5-15 µg · kg–1 · min–1) in 27
patients (4 patients with Kawasaki disease, 5 with ventricular sep-
tal defect, 3 with patent ductus arteriosus, 3 with atrial septal
defect, 3 with pulmonary stenosis, 3 with coarctation of the aorta,
4 with single ventricle, and 2 with dilated cardiomyopathy). The
latter 2 indices can be obtained from the same set of P-A data and
have proven to provide relatively load-insensitive measure of con-
tractility in P-V analysis.4,13,14
Ventricular-vascular coupling. We further tested the ability of
P-A loops and relations to independently quantify changes in ven-
tricular performance and vascular loading when simultaneous
changes in contractility and arterial load occur. In 17 patients (3
with Kawasaki disease, 4 with ventricular septal defect, 2 with
patent ductus arteriosus, 2 with coarctation of the aorta, 2 with atri-
al septal defect, 2 with pulmonary stenosis, and 2 with single ven-
tricle), the P-A relation was analyzed during an intravenous injec-
tion of milrinone, an agent that has both positive inotropic and
vasodilating effects.
Once determined, Ees and Ea can be combined in a coupling
relation to predict EF (Appendix 1):
EF = SAI/EDAI = Ees [1 – (Ao/EDAI)]/(Ea + Ees).
This equation indicates that EF can be predicted as a function
of changes in preload (EDAI), afterload (Ea), and ventricular
contractile state (Ees and Ao). Thus, to better test the validity and
usefulness of the P-A coupling framework in assessing cardio-
vascular dynamics in CHD, we compared predicted and directly
calculated EF.
Basal cardiovascular dynamics of CHD. P-A loops and rela-
tions were then used to assess cardiovascular interaction in various
forms of CHD. Four groups of patients with hemodynamically rep-
resentative CHD were studied: left ventricular (LV) volume over-
load (ventricular septal defect); LV pressure overload (coarctation
of the aorta); right ventricular (RV) volume overload (atrial septal
defect); and RV pressure overload (pulmonary stenosis). LV Ees,
Ea, and their coupling ratios were compared in association with
other hemodynamic variables.
Estimation of ESPAR from a single beat. To determine
ESPAR and thus its coupling with vascular load, multiple P-A
loops with different loading conditions must be generated. This
limits its applicability, particularly in the clinical setting.
Estimation of ESPAR from a single P-A loop would therefore
enhance its clinical value. Methods for estimating single-beat end-
systolic pressure-volume relation (ESPVR) have been proposed by
others,15,16 as well as by us.12 We tested whether the same method
can be applied to P-A loops to obtain ESPAR from a single beat.
The method proposed by Senzaki and colleagues12 is based on
normalized time-varying elastance curves (EN[tN]; Appendix 2).
Our finding that EN(tN) curves in adult human beings were remark-
ably consistent despite variations in underlying cardiac disease,
contractility, loading, and heart rate enables ESPVR to be estimat-
ed from one beat with a known value of EN(tN) at a given tN (nor-
malized time). Accordingly, we first tested whether EN(tN) curves
were consistent among patients with a wide spectrum of CHD
(Appendix 2). Once the standard EN(tN) curve was determined, Ao
and thus Ees were calculated by using a known EN(tN) value and
pressure and area measured at a selected tN (Appendix 3). This Ees
is referred to as Ees(EN).
An alternative method, originally proposed by Sunagawa and
colleagues,15 assumes linear ESPVR and mathematically predicts
peak isovolumic pressure (Piso) by curve fitting isovolumic data
TABLE 1. Patient characteristics
Diagnosis No. of patients Age (y)
Kawasaki disease 7 5.3 ± 5.0 
VSD (2 had significant MR) 16 3.3 ± 3.6 
CoA 5 2.5 ± 4.2 
PDA 5 2.6 ± 2.4 
ASD 6 11 ± 6.2 
PS 6 3.7 ± 4.4 
AVSD 3 0.8 ± 0.7 
S/P Fontan operation 4 10.8 ± 5.0 
SiV 7 1.7 ± 1.7 
DCM 3 9.5 ± 3.5 
Others 4 3.9 ± 5.4 
Total 66 4.3 ± 4.8 
VSD, Ventricular septal defect; MR, mitral regurgitation; CoA, coarctation
of the aorta; PDA, patent ductus arteriosus; ASD, atrial septal defect; PS,
pulmonary stenosis; AVSD, atrioventricular septal defect; S/P, status post;
SiV, single ventricle; DCM, dilated cardiomyopathy.
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from an ejection beat to cosine function, yielding Ees from a sin-
gle beat (Ees[iso]; Appendix 4).
Both Ees(EN) and Ees(iso) were compared with the multiple
beat–derived Ees value (Ees[MB]).
Noninvasive application. Combining aortic pressure and ven-
tricular area data, a P-A loop can be constructed during the ejec-
tion period. Ventricular preload can be noninvasively altered by
abdominal compression to change venous return,17 and thus
ESPAR and its coupling to Ea can be estimated by noninvasive
means. To test the feasibility of this method, we compared Ees
derived from LV pressure during inferior vena caval occlusion
(Ees[LV]) and aortic pressure-based Ees obtained during abdomi-
nal compression (Ees[AO]) in a random subset of 28 patients. Data
were compared both at rest and after increased contractility caused
by administration of dobutamine.
Statistics
Data are presented as means ± standard deviation. The correlation
between 2 variables was tested by means of linear regression
analysis. Effects of dobutamine on contractile indices and the
effects of milrinone on Ees and Ea were tested by means of multi-
variate regression analysis.
Surgery for Congenital Heart Disease Senzaki et al
Figure 1. A, Relation between the measurements of EDAI and ESAI repeated on 2 separate occasions. Linear
regression is shown as solid lines; dashed lines indicate 95% confidence intervals. B, Relation of changes in
stroke area (SA) to simultaneously measured changes in stroke volume (SV) during inferior vena caval occlu-
sion.
Figure 2. Contractile response to dobutamine. A, P-A loops and end-systolic P-A relations before (dotted lines)
and after (solid lines) dobutamine (DOB) infusion. End-systolic elastance increased from 17.1 to 36.6 mm Hg · m2
· cm–2. B, Relations between SWI versus EDAI and between dP/dtmax versus EDAI obtained from the same set
of P-A data in A. Baseline relations are shown by filled circles, and relations after dobutamine infusion are
shown by open circles.
A B
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Results
Validation of Area Measurements by ABD
Figure 1, A, displays scatter plots of the measurements of
ventricular areas repeated on 2 separate occasions. Two
patients with a heart rate change of greater than 10
beats/min were excluded. The plots show good correlation
with little variability (EDAI: y = 0.98x + 0.28, r = 0.99, and
standard error of the estimate [SEE] = 0.69; ESAI: y = 1.0x
+ 0.1, r = 0.99, and SEE = 0.44; both P < .0001). Figure 1,
B, shows pooled data describing the relationship between
stroke area and stroke volume change during inferior vena
caval occlusion. Variables are plotted, with 100% represent-
ing baseline values before inferior vena caval occlusion. The
relationship between the variables was predominantly linear
(r = 0.88 ± 0.08, SEE = 8% ± 4%), with a regression slope
of 0.90 ± 0.18. Five patients with atrial septal defect who
showed paradoxical septal motion were included in these
studies, and their results were not different from those of the
remaining patients, indicating that the effects of paradoxical
septal motion on the accuracy of the area measurements and
the relationship to stroke volume are minimal. Thus, ven-
tricular area measurements by ABD from the transthoracic
approach provided reproducible data and accurately reflect-
ed ventricular volume change.
Contractility Response to a Positive Inotrope
Figure 2, A, displays example plots of P-A loops and relations
before and after dobutamine infusion in a patient with a func-
tional single ventricle after a Fontan operation. The patient
had a double-outlet right ventricle, tricuspid and mitral valve
regurgitation, and multiple ventricular septal defects, includ-
ing a restrictive perimembranous defect with straddling tri-
cuspid valves. P-A analysis for this complicated ventricle
yielded a predominant linear ESPAR that shifted leftward
with increased slope after dobutamine infusion, which is con-
sistent with increased chamber contractility. Figure 2, B,
shows the changes in SWI-EDAI and dP/dtmax-EDAI rela-
tions obtained from the same set of P-A loops. The linear
regression slopes of each relation increased with dobutamine
administration, which is consistent with changes in ESPAR
(increased contractility). Multivariate regression analysis of
data from all patients revealed a significant increase in all 3
variables with dobutamine administration (Ees: 14.1 ± 3.7 to
37.7 ± 19.6 mm Hg · m2 · cm–2; Ao: –2.7 ± 2.1 to –0.78 ± 2.4
cm2/m2; SWI-EDAI: 55.8 ± 14.8 to 104.9 ± 26.2 mm Hg;
dP/dtmax-EDAI: 123.9 ± 68.1 to 352.4 ± 248.2 mm Hg · m–2
· s–1 · cm–2; all P < .001). To confirm that changes in these
indices are due to true alterations in ventricular contractility
but not due to their variability, reproducibility of each index
was tested under steady-state conditions. Measurements
showed little variability with coefficients of variation
(SD/mean × 100) of 8.6% ± 4.9% for Ees, 3.8% ± 2.5% for
stroke work–end-diastolic area relation, and 9.8% ± 5.3% for
dP/dtmax–end-diastolic area relation. Thus, P-A loops and
relations provide load-insensitive contractility indices in
patients with various forms of CHD, as do P-V relations.
Ventricular-Vascular Coupling Framework
Figure 3, A, displays an example set of P-A loops and
changes in ESPAR and Ea before and after milrinone infu-
sion in a patient with a patent ductus arteriosus. The Ees
increased with a concomitant decrease in Ea. Group Ees
Figure 3. A, Example P-A data before and after acute changes in ventricular contractility and afterload with mil-
rinone. P-A loops at baseline and after milrinone infusion are shown by dotted and solid lines, respectively. End-
systolic P-A relations and arterial elastance in each condition are in bold. B, Relationship between predicted
EF by the coupling framework model and measured EF both at rest (filled circles) and after milrinone infusion
(open circles).
A B
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increased from 15.5 ± 8.0 to 28.6 ± 13.1 mm Hg · cm–2 · m2
(Ao from –2.7 ± 2.1 to –0.8 ± 2.4 cm2/m2, P = .02 by means
of a paired t test), and Ea decreased from 26.5 ± 11.1 to 22.3
± 10.3 mm Hg · cm–2 · m2 (both P < .001 by means of a
paired t test). These changes were independent of CHD type
(P < .01 by means of multivariate regression analysis), sug-
gesting that simultaneous changes in ventricular contractili-
ty and vascular loading condition can be separately quanti-
fied by P-A relations in CHD. Changes in Ees and Ea were
in turn coupled to predict the net change in ventricular per-
formance (Figure 3, B). The ventricular-vascular coupling
model based on Ees and Ea changes derived from P-A loops
precisely predicted changes in EF caused by milrinone infu-
sion (r = 0.98 before and after milrinone, P < .001).
Baseline Ventricular-Vascular Interaction in CHD
Figure 4 displays example plots of P-A loops and relations
in various forms of CHD. The P-A relations of a represen-
tative normal control subject are reproduced in each panel
by dotted lines to assist comparison. The heart rate, EF, and
dP/dtmax values for this patient were 110 beats/min, 69%,
and 1540 mm Hg/s, respectively. In each disease 2 condi-
tions are shown in the upper and lower panels. Summary
data are also presented in Table 2. The Ees and Ea values in
normal children were 21.8 ± 7.4 and 24.4 ± 8.2 mm Hg ·
cm–2 · m2, respectively, and their coupling ratios were main-
tained within a relatively small range (0.91 ± 0.21).
P-A loops in patients with a ventricular septal defect
(Figure 4, A) were characterized by increased EDAI and
decreased Ea (both P = .01 vs control subjects), which were
more pronounced with a large left-to-right shunt (lower
panel). The LV contractile state of ventricular septal defect
was also dependent on the amount of shunt, with lower Ees
associated with a high pulmonary/systemic flow ratio (Qp/Qs;
Ees = –3.0 Qp/Qs + 18.5, r = 0.61, P < .01). Although EF or
dP/dtmax values were similar to those of normal patients (P =
Surgery for Congenital Heart Disease Senzaki et al
Figure 4. Example plots of P-A data in CHD (solid lines). Data from a representative normal control subject are
reproduced in each panel to assist comparison (dotted lines). A, Data from patients with a ventricular septal
defect (VSD) in which pulmonary/systemic blood flow ratios (Qp/Qs) were 1.8 (upper panels) and 2.9 (lower pan-
els). B, Data from patients with coarctation of the aorta (CoA). The patient shown in the upper panel had 50 mm
Hg of pressure gradient (∆P) across the coarctation but no heart failure symptoms, and the patient in the lower
panel manifested heart failure symptoms with ∆P of 30 mm Hg.
A B
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.68 for EF and P = .45 for dP/dtmax), ventricular contractility
as represented by Ees or the slope of SWI-EDAI relation was
significantly lower than normal (both P < .01).
Increased afterload caused by coarctation of the aorta
was characterized by increased Ea (P < .01 vs control sub-
jects). The LV contractility (Ees) was markedly enhanced in
response to chronically increased afterload in a 10-year-old
patient, whose data are presented in the upper panel. This
patient had no symptoms of heart failure. The resultant cou-
pling ratio was slightly higher than normal, yielding a pre-
served stroke area despite a decreased EDAI and increased
afterload. Of note, dP/dtmax of this patient was 1520 mm
Hg/s and thus failed to detect increased contractile state. In
contrast, P-A data from a 3-month-old infant who manifest-
ed overt heart failure (lower panel) revealed a minimal
increase in Ees against increased Ea, which is consistent
with afterload mismatch. This resulted in decreased stroke
area and EF compared with those of normal control sub-
jects. Of 5 patients with coarctation, 3 presented symptoms
of heart failure, and their Ees values were significantly
lower than those of the rest of the patients (18.9 ± 2.0 vs
38.2 ± 6.4 mm Hg · m2 · cm–2, P < .01) but not different
from those of control subjects.
The effects of RV loading abnormality on LV perfor-
mance are shown in Figure 4, C and D. Although LV pre-
load was decreased in ASD (decreased EDAI), SAI was
well maintained. Ees, Ea, and thus their coupling ratio were
comparable with those of normal control subjects.
P-A loops and relations of mild pulmonary stenosis
(Figure 4, D) were similar to those of normal control sub-
Figure 4. Cont’d. C, Atrial septal defect (ASD) in which Qp/Qs values were 1.6 (upper panel) and 2.4 (lower panel).
D, Pulmonary stenosis (PS) in which ∆P was 38 mm Hg (upper panel) and 60 mm Hg (lower panel). The patient
in the upper panel was asymptomatic, whereas the patient in the lower panel manifested overt heart failure with
right-to-left shunt through a foramen ovale.
C D
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jects. In contrast, LV preload in severe pulmonary stenosis
(lower panel) was markedly decreased, as indicated by a
small EDAI. A steep ESPAR maximized stroke area under
this loading condition, suggesting enhanced LV contractili-
ty. However, dP/dtmax of this patient was rather small (877
mm Hg/s), mainly because decreased preload and EF (51%)
was subnormal as a result of a small stroke area associated
with a high heart rate (160 beats/min).
Estimation of ESPAR From a Single Beat
Consistent with the data from a P-V study in adults,12 EN(tN)
curves varied relatively little among the patients, particularly
early in contraction. This enabled the prediction of Ees from
a single P-A loop. Figure 5, B, shows a scatter plot of Ees(EN)
versus Ees(MB). The single-beat estimates were the average
of results using tN of 0.25, 0.30, 0.35, and 0.40. These points
were selected because of the relatively small variance in the
standard EN(tN) curve and the stability of Ees calculation at
these time points. The variables correlated relatively well,
with regression given as Ees(MB) = 0.71Ees(EN) + 5.8 
(r = 0.75, P < .001). The relationship between Ees(iso) and
Ees(MB) is also displayed in Figure 4, C. This correlation
was also good, with regression given by Ees(MB) =
0.54Ees(iso) + 6.7 (r = 0.65, P < .001).
Noninvasive Application
Abdominal compression induced increases in EDA in 16
patients (group 1) and decreases in EDA in 12 patients
(group 2). The body surface area of group 1 was significant-
ly lower than that of group 2 (0.53 ± 0.3 vs 0.80 ± 0.32 m2,
P = .04). Thus, the direction of preload change by abdominal
compression apparently depended on body size. Figure 6, A
and B, displays example plots of P-A loops and relations dur-
ing the ejection period obtained by abdominal compression
both at rest (Figure 6, A) and under an increased contractile
state with dobutamine (Figure 6, B) in a representative
patient from group 1. The ESPARs on the basis of aortic
pressure were similar to those from LV pressure during infe-
rior vena caval occlusion. Figure 6, C, shows the baseline
correlation between Ees(AO) and Ees(LV). Group 1 patients
are indicated by filled circles and group 2 patients by open
circles. Regardless of the direction of preload change (P =
.56 by means of analysis of covariance), Ees(AO) correlated
well with Ees(LV) (Ees[LV] = 1.06 Ees[AO] + 0.34; r =
0.89, P < .01). Figure 6, D, compares changes in Ees [LV]
and Ees(AO) caused by dobutamine infusion. ∆Ees [AO]
provided a reasonable prediction of ∆Ees(LV) (∆Ees[LV] =
1.1 ∆Ees[AO] + 2.5; r = 0.81, P < .01). Thus, changes in con-
tractility were accurately estimated by Ees(AO).
Discussion
Traditional evaluation of cardiac function is too often limit-
ed by reliance on measurements with complex interdepend-
ence between cardiac properties and loading factors.4,18 P-V
relation analysis has evolved as a dominant approach to solve
this problem3,4 and has been widely applied both in experi-
mental4,19,20 and clinical studies.21-23 This method is of par-
ticular benefit for pediatric patients with CHD, in whom
baseline loading conditions are generally abnormal and often
change with disease progression or therapeutic intervention.
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TABLE 2. Hemodynamic characteristics and ventricular-vascular interaction in CHD
Control VSD CoA ASD PS
BSA (m2) 0.7 ± 0.39 0.57 ± 0.34 0.60 ± 0.45 1.1 ± 0.5 0.65 ± 0.46
Heart rate (beats/min) 103.2 ± 13.6 121.0 ± 21.0 113.8 ± 24.5 97.5 ± 9.6 113.8 ± 29.5
SAI (cm2/m2) 4.4 ± 0.9 6.2 ± 1.7* 3.6 ± 0.8 4.2 ± 0.9 3.8 ± 2.5
EDAI (cm2/m2) 6.7 ± 1.1 10.3 ± 3.2* 6.3 ± 0.4 5.9 ± 1.3* 6.1 ± 3.2
EF (%) 65.5 ± 9.6 62.1 ± 12.2 59.5 ± 10.7 70.4 ± 11.8 62.1 ± 10.5
ESP (mm Hg) 87.8 ± 6.9 84.9 ± 11.9 119.9 ± 32.7* 92.2 ± 13.9 89.1 ± 19.0
dp/dtmax (mm Hg/s) 1611 ± 432 1449 ± 230 1589 ± 263 1816 ± 529 1492 ± 358
Qp/Qs (VSD and ASD) — 2.3 ± 1.2 — 2.1 ± 0.8 —
∆P (mm Hg; CoA and PS) — — 36.5 ± 16.5 — 37.3 ± 12.5
Msw (mm Hg) 66.4 ± 4.2 54.7 ± 12.7* 77.9 ± 24.9 71.3 ± 17.8 62.3 ± 12.1
Ees (mm Hg · m2 · cm–2) 21.8 ± 7.4 11.6 ± 4.4* 26.7 ± 11.1 23.4 ± 8.6 25.2 ± 8.3
Ao (cm2/m2) –2.3 ± 2.3 –4.7 ± 4.2 –0.9 ± 1.5 –3.8 ± 0.8 –1.2 ± 2.2
Ea (mm Hg · m2 · cm–2) 24.4 ± 8.2 16.4 ± 4.4* 34.3 ± 5.3* 28.9 ± 13.5 28.8 ± 4.9
Ees/Ea 0.91 ± 0.21 0.75 ± 0.28 0.76 ± 0.23 0.87 ± 0.26 0.87 ± 0.21
CHD, Congenital heart disease; VSD, ventricular septal defect; CoA, coarctation of the aorta; ASD, atrial septal defect; PS, pulmonary stenosis; SAI, stroke
area index; BSA, body surface area; EDAI, end-diastolic area index; EF, ejection fraction; ESP, end-systolic pressure; Qp/Qs, pulmonary/systemic flow ratio;
∆P, pressure gradient across the stenotic site; Msw, the slope of the stroke work–EDAI relation; Ees, end-systolic elastance; Ao, intercept; Ea, effective
arterial elastance.
*P < .05 versus control by analysis of variance.
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The present study demonstrated for the first time the
applicability of underlying concepts of P-V analysis to
various forms of CHD by using P-A analysis. Ventricular
area measured by ABD was highly reproducible, and area
changes during load manipulation adequately reflected
volume changes. The area data combined with pressure
recordings provided load-independent measures of con-
tractility, allowing the contractility and loading conditions
to be separately quantified. These features of P-A analy-
sis should be of significant clinical value for the cardio-
vascular assessment of CHD. P-A analysis clarified ven-
tricular contractile states under various loading conditions
in CHD, which was not necessarily true of conventional
indices because of load dependence. Furthermore, P-A
relation analysis could be extended to a simplified and
less invasive method. Thus, this approach should provide
a useful modality for more detailed assessments of car-
diovascular dynamics in pediatric patients with CHD and
thereby help in improving the management of patients
with this disease.
Area Measurements With ABD in Pediatric Patients
With Heart Disease
The conductance catheter24 enables measurements of
instantaneous ventricular volume and has accelerated the
application of P-V analysis to human subjects. However, a
catheter of the appropriate size for the hearts of infants or
small children is not currently available. More important,
complex anatomy, particularly that associated with an inter-
ventricular communication (including single ventricle), may
affect segmental volume determination, making the inter-
pretation of calculated total volume ambiguous. Significant
RV volume loading may also affect the LV volume signal
during load manipulation.25 In this regard instantaneous
area measurement by ABD has advantages because it can be
applied regardless of ventricular morphology or right heart
volume. It may also be used in mitral valve regurgitation,
where a volume catheter cannot be used because of large
signal artifacts.25 A good example is presented in Figure 2.
The conductance catheter cannot be used to construct P-V
relations for this complicated ventricle. In addition, ABD
has another advantage in that it is far less invasive and com-
plicated compared with a conductance catheter, and it may
enable a fully noninvasive P-A analysis, as shown in the
present study (Figure 6).
Although area measurement with ABD has many benefits,
as noted above, several limitations must be considered. First,
there is the potential for lateral translation of the ventricle dur-
ing varying preloads, resulting in artifactual measurements.
However, the linear correlation between changes in stroke area
and stroke volume (Figure 1, B) suggests that the degree of ven-
tricular translation appeared minimal. Second, the P-A relation
may not be applied to a ventricle with regional dysfunction or
with abnormal activation, such as a left anterior hemiblock.
Little and colleagues26 reported that pressure-dimension rela-
tions can be used to assess global but not regional chamber dys-
function. Although area has an additional dimension and may
still reflect volume change of ventricle with mild regional wall
motion abnormalities,27 the quantitative effects of a segmental
myocardial abnormality on P-A analysis remain to be elucidat-
ed before application to such ventricles.
Figure 5. A, Averaged normalized elastance curve (EN[tN]). Solid lines show means, and dashed lines show ± 1
standard deviation. B, Scatterplot between single-beat estimated Ees on the basis of EN(tN) curve (Ees[EN]) and
Ees(MB) during caval occlusion. C, Scatterplot between single-beat estimated Ees by curve fitting (Ees[iso]) and
Ees(MB). Linear regression is shown as solid lines; 95% prediction interval is shown as dashed lines.
A B C
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Load-insensitive Measures of Contractility
The linear slope of dP/dtmax–end-diastolic volume and stroke
work–end-diastolic volume relations, as well as Ees, can be
obtained from the same set of P-V data and can characterize
relatively load-independent chamber contractility. The present
study also demonstrated that similar relations could be
obtained by using P-A analysis and that these relations con-
sistently reflected ventricular inotropic change with dobuta-
mine in various forms of CHD. These 3 indices have different
levels of sensitivity and stability in the assessment of inotrop-
ic changes28 and should provide more accurate information
about chamber contractile states in a compensatory manner.
The adequacy of area measurements with ABD and the
behavior of ESPAR with a contractile state presented in this
study are consistent with the results of studies conducted in
open chest–operated dogs with a transducer placed on the
epicardium29 or in human adults by using transesophageal
echocardiography.30 Our data indicated that P-A analysis is
also feasible from the transthoracic approach and applicable
even to morphologically abnormal ventricles.
Ventricular-Vascular Coupling
The notable advantage of the concept of P-V analysis is
that it provides a description of coupling between the ven-
tricle and the vasculature by independent indices with a
common term for chamber and loading properties.4,31 The
present study demonstrated that such features of P-V rela-
tion could be conveyed with P-A analysis (Figure 3). This
is extremely useful for CHD, where baseline loading con-
ditions are generally abnormal, and pharmacologic or
mechanical intervention often alter them significantly. If
chamber properties and loading conditions are identified,
therapeutic targets can be more clearly focused, and
effects from therapeutic intervention can be evaluated
more precisely. These should greatly contribute to the
improvement of preoperative/postoperative management
of patients with CHD.
Ventricular-Vascular Coupling in CHD
By using P-A relations, the present study is the first to
reveal basal cardiovascular interaction in various forms of
Surgery for Congenital Heart Disease Senzaki et al
Figure 6. Noninvasive estimation of ESPAR. Example of P-A data before (A) and after (B) dobutamine. P-A loops
and relations on the basis of ventricular pressure during caval occlusion are shown by dotted lines and those
obtained from aortic pressure during abdominal compression by solid lines. Relations were similar before and
after inotropic change. Group data comparing aortic pressure based Ees (Ees[Ao]) versus ventricular pres-
sure–based Ees (Ees[LV]) at baseline (C) and ∆Ees(Ao) versus ∆Ees(LV) after dobutamine (D).
A C
B D
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CHD. The P-A relations clearly characterized diverse LV
contractile responses against persistent abnormal loading in
association with type and severity, whereas the predomi-
nant load dependence of conventional indices confounded
such responses.
The LV contractility of ventricular septal defect was
rather decreased, despite a normal range of EF. It has been
reported that ventricular septal defect is associated with the
hypercatecholamic state and that LV contractility is not
impaired when assessed by means of EF or circumferential
shortening velocity.32,33 However, the present study
revealed that the maintained EF of ventricular septal defect
does not necessarily reflect normal contractility but the con-
sequence of decreased afterload resulting from shunt-asso-
ciated increased stroke volume. This situation may be anal-
ogous to that in mitral valve regurgitation, where LV
preload is increased and afterload is decreased as a result of
increased stroke volume. Nagatsu and colleagues34 reported
that LV contractility measured by using a load-insensitive
index was decreased in experimental mitral valve regurgita-
tion, despite preserved EF by increased β-adrenergic sup-
port. Because measures of contractility had been shown to
be normal, White and Lietman35 proposed in 1978 that there
was no clear rationale for the use of digoxin in patients with
ventricular septal defect.36 Since then, no definite conclu-
sions have been reached in this regard. The results of the
present study provide in part supportive evidence for the use
of digoxin.
In general, 2 types of clinical manifestation are recog-
nized in patients with coarctation of the aorta.37 One is in
infants with coarctation who present symptoms of heart fail-
ure, and the other is in patients who do not present with
symptoms as infants but are recognized as children or ado-
lescents with a significant pressure gradient and LV hyper-
trophy. Our data demonstrated that such differences
stemmed from the different LV contractile response to
increased afterload. LV contractility increased and matched
the afterload in compensated coarctation of the aorta but not
in infant-onset coarctation. The P-A diagram predicts that
markedly increased afterload inevitably causes a decrease in
stroke volume and EF unless Ees increases to a level match-
ing Ea. For example, if the Ees of the patient presented in
the lower panel of Figure 4, B, increases to produce a simi-
lar level of stroke area and EF in the patient presented in the
upper panel, then LV peak pressure will rise as high as 160
mm Hg. This may be rather harmful to the LV myocardium
of infants. Thus, whether a lack of compensation in symp-
tomatic infants with coarctation of the aorta is due to the
protective adaptation of LV or simply the transition from
compensation to decompensation is of particular interest,
and further studies are needed to clarify this.
LV contractile responses in atrial septal defect and pul-
monary stenosis appeared to be dependent mainly on the LV
preload reserve. Most patients with atrial septal defect have
a left ventricle that is only slightly smaller than normal and
are asymptomatic until adulthood, despite a significant left-
to-right shunt.38 The preserved stroke area with normal ven-
tricular-vascular interaction, as shown in Figure 4, C, sup-
ports this fact. Although mild pulmonary stenosis had
minimal effects on LV hemodynamics, as in atrial septal
defect, severe pulmonary stenosis significantly limited LV
preload, leading to enhanced LV contractility to maintain
systemic blood flow.
It is again emphasized that these changes in LV contrac-
tility associated with loading alterations were not necessar-
ily delineated by using traditional measures of cardiac func-
tion, such as EF or dP/dtmax, because of their predominant
load dependence.
Single-Beat Estimation of ESPAR
One important finding of this study was the uniformity of
the normalized elastance curve, EN(tN), among a variety of
CHD types (Figure 5, A). This suggests that the time course
of ventricular activation is conserved, despite a morpholog-
ic and hemodynamic abnormality. This also implies the
applicability of time-varying elastance models, the underly-
ing concept of P-V relations, to pediatric patients with CHD
and supports the validity of P-A analysis.
In addition to the physiologic insight provided by the
consistent EN(tN) curve among patients, it also has an
important practical implication. With the standard EN(tN)
curve, Ees could be estimated from a single P-A loop
(Figure 5, B). A curve-fitting method (EN[iso]) also provid-
ed reasonable estimates of Ees (Figure 5, C). These methods
are clearly advantageous over complex methods of generat-
ing multiple variably loaded cardiac cycles and should
enhance their utility. Although these methods yielded rea-
sonable estimates for Ees derived from multiple P-A loops,
some estimation errors remained. Introducing adjustments
for individual elastance variability39 or normalizing the
amplitude and duration of isovolumic pressure waves40 may
further improve the single-beat method and therefore war-
rant future studies.
Noninvasive Approach
The present study demonstrated that Ees could be estimated
from aortic pressure and ventricular area by using ABD com-
bined with abdominal compression. Central aortic pressure
has been estimated with tonometers applied to either the
carotid or the subclavian pulse and calibrated with peripher-
al cuff pressures.41 Mathematic translation42 from radial or
brachial arterial pressure to central aortic pressure may fur-
ther facilitate the accurate and easy estimation of central aor-
tic pressure with noninvasive technology. Thus, EAPAR and
its coupling to arterial loads (Ea) can be estimated by using
a fully noninvasive method. The noninvasive applicability of
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P-A analysis not only reduces the risk and burden associated
with catheterization, but it could also have wider practical
applications. A noninvasive method enables repeated assess-
ments, which could contribute to the earlier detection of dis-
ease progression. This is very useful and important for the
preoperative and postoperative management of patients with
CHD and helps to determine the appropriate timing of
catheter-surgical (re)intervention. Furthermore, recording
data from large groups of patients not requiring cardiac
catheterization is also feasible. This should help reveal car-
diovascular (dys)function and improve the management of
patients with diseases and conditions not directly associated
with heart disease but potentially influencing cardiovascular
function, such as diabetes mellitus, growth hormone defi-
ciency, or chemotherapy in malignancy. These studies are
currently underway by using tonometry and ABD.
In summary, the present study demonstrated for the first
time the applicability of the concept of the P-V framework
to pediatric patients with CHD by using ABD-based P-A
relations. The methods conveyed all the benefits of P-V
analysis and have potential for noninvasive application.
Baseline P-A relations varied with the severity and types of
loading abnormality in various forms of CHD. This method
would help improve the management of pediatric patients
with cardiovascular disease.
We thank the medical engineers of Saitama Medical School
Hospital for valuable technical assistance in performing the pres-
sure-area studies.
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Appendix 1
By definition, Ees and Ea can be described as follows:
Ees = ESP/(ESA – Ao) = ESP/(ADA – SA – Ao) (1)
Ea = ESP/SA (2)
where ESP is end-systolic pressure, ESA is end-systolic area, and
SA is stroke area.
Combining equations 1 and 2 yields the following:
SA = Ees(EDA – Ao)/(Ea + Ees) (3)
where EDA is end-diastolic area. Thus,
EF = SA/EDA = Ees[1 – (Ao/EDA)]/(Ea + Ees) (4)
Appendix 2
Time-varying elastance (E[t]) was defined as the instantaneous
ratio of P(t)/[A(t) – Ao], where P(t) and A(t) are ventricular pres-
sure and area at time t. The maximal value of E(t) (Emax) and the
time to achieve Emax referenced from the R wave of the electro-
cardiogram (tmax) were both determined. The normalized E(t)
function was then defined as follows:
EN(tN) = E(tN)/Emax (5) 
where
tN = t/tmax (6)
To combine EN(tN) relations, each curve was resampled at 200
equispaced intervals by using linear interpolation, and the results
were averaged, yielding a standard EN(tN) curve.
Appendix 3
Chamber elastance at time tN was as follows:
E(tN) = P(tN)/[A(tN) – Ao] (7)
Elastance at time tmax was as follows:
E(tmax) = Emax = P(tmax)/[V(tmax) – Ao] (8)
From equation 5, the ratio of E(tN)/Emax equaled EN(tN). Thus,
combining equations 5, 7, and 8 yielded the following:
Ao = [PN(tN) × A(tmax) – A(tN) × EN(tN)]/[PN(tN) – EN(tN)] (9)
where PN(tN) = P(tN)/P(tmax). Once Ao was calculated, Emax was
determined from equation 8. This Emax value was referred to as
Ees(EN).
Appendix 4
For each steady-state beat, pressure data between end-diastolic
pressure and dP/dtmax and between dP/dtmin and the point at
which pressure declined to end-diastolic pressure were fit by
means of nonlinear regression to the following formula:
P(t) = 0.5 × Piso × [1 – cos(ωt + φ)] + EDP (10)
where EDP was end-diastolic pressure and Piso was the esti-
mated peak isovolumic pressure. Ees (Ees[iso]) was then calculat-
ed from the following:
Ees(iso) = [Piso – ESP]/[EDA – ESA] (11)
